Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R N JONES

Showing results (781-790 of 818) with videos related to

Pageof 82
Sort By:
Journal of Clinical Microbiology|June 1, 1995
Multicenter clinical laboratory evaluation of a beta-lactamase disk assay employing a novel chromogenic cephalosporin, S1G V Doern, R N Jones, E H Gerlach, et al.
Diagnostic Microbiology and Infectious Disease|September 1, 1991
Development of Neisseria gonorrhoeae in vitro susceptibility test methods for cefixime including quality control guidelinesR N Jones, E H Gerlach, F P Koontz, et al.
The Journal of Antimicrobial Chemotherapy|March 7, 2000
Activity and spectrum of 22 antimicrobial agents tested against urinary tract infection pathogens in hospitalized patients in Latin America: report from the second year of the SENTRY antimicrobial surveillance program (1998)A C Gales, R N Jones, K A Gordon, et al.
The Journal of Thoracic and Cardiovascular Surgery|March 1, 1981
Characteristics of chronic left ventricular hypertrophy induced by subcoronary valvular aortic stenosis. II. Response to ischemiaD E Attarian, R N Jones, W D Currie, et al.
The Journal of Allergy and Clinical Immunology|October 1, 1981
Immune complexes and autoantibodies in silicosisN J Doll, R P Stankus, J Hughes, et al.
Journal of Clinical Microbiology|April 16, 1999
Methicillin-resistant Staphylococcus aureus outbreak in a veterinary teaching hospital: potential human-to-animal transmissionJ C Seguin, R D Walker, J P Caron, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 11, 2004
Results of two worldwide surveys into physician awareness and perceptions of extended-spectrum beta-lactamasesH Goossens, S Malhotra-Kumar, H Eraksoy, et al.
Diagnostic Microbiology and Infectious Disease|August 1, 1992
Cefdinir (FK482), an orally administered cephalosporin in vitro activity comparison against recent clinical isolates from five medical centers and determination of MIC quality control guidelinesE H Gerlach, R N Jones, S D Allen, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|September 1, 1991
Antimicrobial activity of RU29246 (HR916 metabolite) compared with four other oral beta-lactams tested against more than 5000 clinical isolatesP R Murray, S D Allen, M E Erwin, et al.
The Journal of Thoracic and Cardiovascular Surgery|March 1, 1981
Characteristics of chronic left ventricular hypertrophy induced by subcoronary valvular aortic stenosis. I. Myocardial blood flow and metabolismD E Attarian, R N Jones, W D Currie, et al.
Pageof 82

Showing results (781-790 of 818) with videos related to

Sort By:
Pageof 82
Journal of Clinical Microbiology|June 1, 1995
Multicenter clinical laboratory evaluation of a beta-lactamase disk assay employing a novel chromogenic cephalosporin, S1G V Doern, R N Jones, E H Gerlach, et al.
Diagnostic Microbiology and Infectious Disease|September 1, 1991
Development of Neisseria gonorrhoeae in vitro susceptibility test methods for cefixime including quality control guidelinesR N Jones, E H Gerlach, F P Koontz, et al.
The Journal of Antimicrobial Chemotherapy|March 7, 2000
Activity and spectrum of 22 antimicrobial agents tested against urinary tract infection pathogens in hospitalized patients in Latin America: report from the second year of the SENTRY antimicrobial surveillance program (1998)A C Gales, R N Jones, K A Gordon, et al.
The Journal of Thoracic and Cardiovascular Surgery|March 1, 1981
Characteristics of chronic left ventricular hypertrophy induced by subcoronary valvular aortic stenosis. II. Response to ischemiaD E Attarian, R N Jones, W D Currie, et al.
The Journal of Allergy and Clinical Immunology|October 1, 1981
Immune complexes and autoantibodies in silicosisN J Doll, R P Stankus, J Hughes, et al.
Journal of Clinical Microbiology|April 16, 1999
Methicillin-resistant Staphylococcus aureus outbreak in a veterinary teaching hospital: potential human-to-animal transmissionJ C Seguin, R D Walker, J P Caron, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 11, 2004
Results of two worldwide surveys into physician awareness and perceptions of extended-spectrum beta-lactamasesH Goossens, S Malhotra-Kumar, H Eraksoy, et al.
Diagnostic Microbiology and Infectious Disease|August 1, 1992
Cefdinir (FK482), an orally administered cephalosporin in vitro activity comparison against recent clinical isolates from five medical centers and determination of MIC quality control guidelinesE H Gerlach, R N Jones, S D Allen, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|September 1, 1991
Antimicrobial activity of RU29246 (HR916 metabolite) compared with four other oral beta-lactams tested against more than 5000 clinical isolatesP R Murray, S D Allen, M E Erwin, et al.
The Journal of Thoracic and Cardiovascular Surgery|March 1, 1981
Characteristics of chronic left ventricular hypertrophy induced by subcoronary valvular aortic stenosis. I. Myocardial blood flow and metabolismD E Attarian, R N Jones, W D Currie, et al.
Pageof 82